Alnylam Pharmaceuticals | Zahlungsmittel Und Äquivalente



Cash And Equivalent Veränderung Datum
Acadia Pharmaceuticals USD 681.58M 74.42M 2025-03
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Amgen USD 8.81B 3.16B 2025-03
Arrowhead Research USD 185.71M 133.92M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Incyte USD 2.41B 720.83M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Moderna USD 1.62B 304M 2025-03
Neurocrine Biosciences USD 233M 116.1M 2024-12
Novartis USD 11.46B 2.15B 2024-12
PTC Therapeutics USD 2.03B 1.25B 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Sanofi 7.44B 646M 2024-12
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
Takeda JPY 385.11B 109.01B 2025-03
Tectonic Therapeutic USD 141.24M 17.86M 2024-12
Ultragenyx Pharmaceutical USD 563M 389.27M 2025-03
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12
Xencor USD 39.67M 1.2M 2025-03



Alnylam Pharmaceuticals Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.